ICYMI one of the top 5% research outputs rated at @AltMetric is this cell therapies review from Medigene CSO Dolores Schendel https://t.co/MI51EbbKX8
3,920 followers
12,163 followers
RT @FrontOncology: New research: Evolution by innovation as a driving force to improve TCR-T therapies: Adoptive cell therapies continually…
6,538 followers
New research: Evolution by innovation as a driving force to improve TCR-T therapies: Adoptive cell therapies continually evolve through science-based innovation. Specialized innovations for TCR-T therapies are described here that are embedded… #oncology ht
3,920 followers
Review: Evolution by innovation as a driving force to improve TCR-T therapies https://t.co/jCkQDjYAjn ( article by Prof. Dolores Schendel, CSO at Medigene ) #TCRT #TCR #ACT #celltherapy